|
MRFAP1L1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6823209492145E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.26350000023901E-07 |
| Normal-vs-Stage2 |
8.6028999479737E-09 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
3.56209999999857E-05 |
| Stage1-vs-Stage2 |
6.238300E-02 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
4.138800E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
2.347600E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.74003042477489E-12 |
| Normal-vs-AfricanAmerican |
2.191200E-01 |
| Normal-vs-Asian |
4.126400E-02 |
| Caucasian-vs-AfricanAmerican |
7.685200E-01 |
| Caucasian-vs-Asian |
1.554430E-01 |
| AfricanAmerican-vs-Asian |
5.693000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.92719999970015E-07 |
| Normal-vs-Female |
1.04030006831124E-10 |
| Male-vs-Female |
5.115000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.17729999999672E-05 |
| Normal-vs-Extreme_Weight |
1.33239999999812E-06 |
| Normal-vs-Obese |
8.11990000000318E-05 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
6.153800E-01 |
| Normal_Weight-vs-Obese |
6.498800E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
9.293000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.63899999999973E-05 |
| Normal-vs-Age(41-60Yrs) |
9.92239999999533E-05 |
| Normal-vs-Age(61-80Yrs) |
8.09200484397365E-11 |
| Normal-vs-Age(81-100Yrs) |
1.54519999999714E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.787400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.993600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.219000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.145010E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.972760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.560000E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
7.080000E-01 |
| Normal-vs-Grade 3 |
8.140600E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
8.971000E-01 |
| Grade 2-vs-Grade 4 |
7.080000E-01 |
| Grade 3-vs-Grade 4 |
8.140600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.71910313446256E-11 |
| Normal-vs-N1 |
2.061100E-03 |
| N0-vs-N1 |
6.318400E-01 |
|
|
